Comorbidity of major depression and migraine - A Canadian population-based study

Canadian Journal of Psychiatry

Volumn 50, Issue 13, 2005, Pages 832-837

  Molgat, Carmen V ^a,c   Patten, Scott B ^a,b,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Comorbidity; Major depressive episode; Migraine; Prevalence

Indexed keywords

ADULT; CANADA; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIGRAINE; POPULATION; REVIEW; SELF REPORT; STATISTICS;

EID: 31544449987     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370505001305     Document Type: Review

References (43)

1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, and others. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
2. Simon GE. Social and economic burden of mood disorders. Biol Psychiatry 2003;54:208-15.
3. Patten SB. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. J Affect Disord 2001;63:35-41.
4. Evans DL, Charney DS. Mood disorders and medical illness: a major public health problem. Biol Psychiatry 2003;54:177-80.
5. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res 2002;53:859-63.
6. McBeth J, Macfarlane GJ, Silman AJ. Does chronic pain predict future psychological distress? Pain 2002;96:239-45.
7. Gagnon LM, Patten SB. Major depression and its association with long-term medical conditions. Can J Psychiatry 2002;47:149-52.
8. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003;61:1524-7.
9. Silberstein SD, Lipton RB. Epidemiology of migraine. Neuroepidemiology 1993;12:179-94.
10. Mattsson P, Ekselius L. Migraine, major depression, panic disorder, and personality traits in women aged 40-74 years: a population-based study. Cephalalgia 2002;22:543-51.
11. Fasmer OB. The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia 2001;21:894-9.
12. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: Is the association specific to migraine? Neurology 2000;54:308-13.
13. Silberstein SD. Shared mechanisms and comorbidities in neurologic and psychiatric disorders. Headache 2001;41(Suppl 1):S11-S17.
14. Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry 2000;57:945-50.
15. Breslau N. Psychiatric comorbidity in migraine. Cephalalgia 1998;18(Suppl 22):56-8.
16. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991;37:11-23.
17. Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res 1993;27:211-21.
18. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994;44(Suppl 7):S17-S22.
19. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res 1993;27:197-210.
20. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990;47:849-53.
21. Canadian Community Health Survey: Mental Health and Well-Being. Available: www.statcan.ca/english/freepub/82-617-XIE/. Accessed 2005 Sept 29.
22. Kessler RC, Andrews. The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Methods Psychiatr Res 1998;7:171-85.
23. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988;145:976-81.
24. Moldin SO, Scheftner WA, Rice JP, Nelson E, Knesevich MA, Akiskal H. Association between major depressive disorder and physical illness. Psychol Med 1993;23:755-61.
25. Patten SB. Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry 1999;44:151-7.
26. Granella F, Cavallini A, Sandrini G, Manzoni GC, Nappi G. Long-term outcome of migraine. Cephalalgia 1998;18(Suppl 21):30-3.
27. Migraine, depression, and "internal" environmentalism. Headache 2002;42:843-4.
28. Breslau N. Migraine, suicidal ideation, and suicide attempts. Neurology 1992;42:392-5.
29. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216-26.
30. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003;60:1308-12.
31. Merikangas KR, Stevens DE, Merikangas JR, Katz CB, Glover V, Cooper T, and others. Tyramine conjugation deficit in migraine, tension-type headache, and depression. Biol Psychiatry 1995;38:730-6.
32. 4 receptors on lymphocytes. Cephalalgia 2000;20:15-9.
33. Montagna P, Cevoli S, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, and others. The genetics of chronic headaches. Neurol Sci 2003;24(Suppl 2):S51-S56.
34. Barbanti P, Fabbrini G, Vanacore N, Rum A, Lenzi GL, Meco G, and others. Dopamine and migraine: does Parkinson's disease modify migraine course? Cephalalgia 2000;20:720-3.
35. Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse 1991;9:251-301.
36. Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 2001;13:1009-23.
37. Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia 2002;22:491-512.
38. Pinsker W. Potentially safe and effective new treatment for migraine? Headache 1993;33:163.
39. Sheftell FD, Atlas SJ. Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application. Headache 2002;42:934-44.
40. Adelman LC, Adelman JU, Von Seggern R, Mannix LK. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000;40:572-80.
41. Goadsby PJ. The scientific basis of medication choice in symptomatic migraine treatment. Can J Neurol Sci 1999;26(Suppl 3):S20-S26.
42. Miranda H, Ortiz G, Figueroa S, Perez CM, Suarez E. Depression scores following migraine treatment in patients attending a specialized center for headache and neurology. Headache 2001;41:680-4.
43. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988;8(Suppl 7):1-96.